Litcius/Paper detail

Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial

Stephen Bagley, Arati Desai, Joseph A. Fraietta, Dana Silverbush, Daniel Chafamo, Nelson F. Freeburg, G. Gopikrishna, Andrew J. Rech, Ali Nabavizadeh, Linda J. Bagley, Jungmin Park, Danuta Jarocha, Rene Martins, Nicolas Sarmiento, Eileen Maloney, Lester Lledo, Carly Stein, Amy Marshall, Rachel Leskowitz, Julie K. Jadlowsky, Shane Mackey, Shannon Christensen, Bike Su Oner, Gabriela Plesa, Andrea Brennan, Vanessa Gonzalez, Fang Chen, David M. Barrett, Robert Colbourn, MacLean P. Nasrallah, Zissimos P. Mourelatos, Wei‐Ting Hwang, Cécile Alanio, Don L. Siegel, Carl H. June, Elizabeth O. Hexner, Zev A. Binder, Donald M. O’Rourke

2025Nature Medicine66 citationsDOIOpen Access PDF

Topics & Concepts

Bivalent (engine)GlioblastomaCancer researchMedicineInternal medicineChemistryOrganic chemistryMetalCAR-T cell therapy researchNanowire Synthesis and ApplicationsVirus-based gene therapy research
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial | Litcius